Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Psomas

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Open AIDS Journal|May 30, 2017
Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed ViremiaMehwish Younas, Christina Psomas, Vikram Mehraj, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
Journal of Virus Eradication|July 28, 2018
Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global healthChristina Psomas, Sabine Kinloch, Caroline Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
Plos One|September 23, 2021
An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patientsPhilippe Halfon, Guillaume Penaranda, Hacène Khiri, et al.
Nature|March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature|June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2014
The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strainsCharline Duquenne, Christina Psomas, Sandrine Gimenez, et al.
Journal of Virus Eradication|April 25, 2017
Highlights from the 24<sup>th</sup> Conference on Retroviruses and Opportunistic Infections: 13-16 February 2017, Seattle, Washington, USATrevor A Crowell, Hermione Lyall, Eva Malatinkova, et al.
AIDS (London, England)|September 20, 2017
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signalingCharline Duquenne, Sandrine Gimenez, Adeline Guigues, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Open AIDS Journal|May 30, 2017
Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed ViremiaMehwish Younas, Christina Psomas, Vikram Mehraj, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
Journal of Virus Eradication|July 28, 2018
Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global healthChristina Psomas, Sabine Kinloch, Caroline Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
Plos One|September 23, 2021
An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patientsPhilippe Halfon, Guillaume Penaranda, Hacène Khiri, et al.
Nature|March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature|June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2014
The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strainsCharline Duquenne, Christina Psomas, Sandrine Gimenez, et al.
Journal of Virus Eradication|April 25, 2017
Highlights from the 24<sup>th</sup> Conference on Retroviruses and Opportunistic Infections: 13-16 February 2017, Seattle, Washington, USATrevor A Crowell, Hermione Lyall, Eva Malatinkova, et al.
AIDS (London, England)|September 20, 2017
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signalingCharline Duquenne, Sandrine Gimenez, Adeline Guigues, et al.
Pageof 3